Volume 85, Issue 2, Pages (January 2014)

Slides:



Advertisements
Similar presentations
Chapter 1: Definition and classification of CKD Kidney International Supplements Volume 3, Issue 1, Pages (January 2013) DOI: /kisup
Advertisements

Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward  Adeera Levin, Paul E. Stevens  Kidney International 
Parathyroid hormone measurement in CKD
Volume 75, Issue 1, Pages 7-9 (January 2009)
Anemia management in chronic kidney disease
No difference in bleeding risk between subcutaneous enoxaparin and heparin for thromboprophylaxis in end-stage renal disease  Kevin E. Chan, Ravi I. Thadhani,
Volume 83, Issue 3, Pages (March 2013)
Blaithin A. McMahon, Patrick Thomas Murray  Kidney International 
Shining light on vitamin D trials in chronic kidney disease
Innate immunity as a driving force in renal disease
Prehypertension and chronic kidney disease: the ox or the plow?
Status of chronic kidney disease prevention programs: International Federation of Kidney Foundation Members 2005/2007  Joanna M. Smith, Susan A. Mott,
Reassessment of the care of the patient with chronic kidney disease
John P. Middleton, Patrick H. Pun  Kidney International 
Volume 77, Issue 1, Pages 6-8 (January 2010)
Jeffrey C. Fink, Glenn M. Chertow  Kidney International 
Volume 77, Issue 1, Pages 5-6 (January 2010)
Methotrexate in the urine
Comorbidity and confounding in end-stage renal disease
The importance of increased dialysis and anemia management for infant survival in pregnant women on hemodialysis  Sai Subhodhini Reddy, Jean L. Holley 
Volume 74, Issue 3, Pages (August 2008)
The new role of calcimimetics as vasculotropic agents
YouFei Guan, M.D., Ph.D., Matthew D. Breyer  Kidney International 
Punit Yadav, Nelson Leung, Paul W. Sanders, Paul Cockwell 
Volume 70, Issue 11, Pages (December 2006)
Volume 76, Issue 11, Pages (December 2009)
Volume 74, Issue 5, Pages (September 2008)
Nephrology Crosswords: Hemodialysis
Volume 71, Issue 11, Pages (June 2007)
Pieter Evenepoel, Björn K. Meijers  Kidney International 
Volume 63, Issue 1, Pages 1-11 (January 2003)
Infected glomerulus Kidney International
Fructose intake as a risk factor for kidney stone disease
Volume 73, Issue 12, Pages (June 2008)
Volume 76, Issue 6, Pages (September 2009)
A physician's perseverance uncovers problems in a key nephrology study
Extracorporeal therapy in sepsis: are we there yet?
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Tilman B. Drüeke, Ziad A. Massy  Kidney International 
Volume 85, Issue 5, Pages (May 2014)
Volume 74, Issue 8, Pages (October 2008)
Nephrology Crossword: Peritoneal Dialysis
Calcium sensing in podocytes
Methods for guideline development
The global challenge of chronic kidney disease
Nephrology Crossword: Glomerulonephritis
Unilateral renal cystic disease
Hydrogen: another gas with therapeutic potential
A man with a hole in his penis
Prehypertension: is it relevant for nephrologists?
It's not over till the last glomerulus forms
Volume 82, Issue 9, Pages (November 2012)
Leptin and inflammation-associated cachexia in chronic kidney disease
Cardio-Kidney-Damage: a unifying concept
Pablo A. Ureña Torres, Marc De Broe  Kidney International 
Volume 80, Issue 10, Pages (November 2011)
Is it the low-protein diet or simply the salt restriction?
Immunoregulatory role of TNFα in inflammatory kidney diseases
Cardiovascular risk in chronic kidney disease
Tobias Breidthardt, Alexandre Mebazaa, Christian E. Mueller 
Volume 75, Issue 7, Pages (April 2009)
Are we really dressed to kill?
Hisataka Kobayashi, Peter L. Choyke  Kidney International 
T cells and T-cell receptors in acute renal failure
The international realities of live donor kidney transplantation
Volume 74, Issue 10, Pages (November 2008)
Volume 75, Issue 8, Pages (April 2009)
Josée Bouchard, Ravindra L. Mehta  American Journal of Kidney Diseases 
Sugar-sweetened beverages and chronic disease
Presentation transcript:

Volume 85, Issue 2, Pages 238-240 (January 2014) Soluble fms-like tyrosine kinase-1 and atherosclerosis in chronic kidney disease  Friedrich C. Luft  Kidney International  Volume 85, Issue 2, Pages 238-240 (January 2014) DOI: 10.1038/ki.2013.402 Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 1 The VEGF/PlGF receptor is Flt-1, a tyrosine kinase receptor. The shorter splice variant is soluble and can bind agonist, thereby abrogating Flt-1 activation. Kidney International 2014 85, 238-240DOI: (10.1038/ki.2013.402) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 2 Model of the third immunoglobulin domain of sFlt-1 protein. The spatial structure, including the heparin-binding epitopes of sFlt-1, is shown by means of a computer-generated model. A stretch of 10 amino acids from 272–281 that constitutes the major heparin-binding domain is highlighted. (Illustration supplied through the courtesy of Thadhani et al. and publisher.5) Kidney International 2014 85, 238-240DOI: (10.1038/ki.2013.402) Copyright © 2014 International Society of Nephrology Terms and Conditions